Xconomy Forum: What's Hot in Boston Biotech
12:30 – 1:30Registration
1:30 – 1:40
Bob Buderi, Editor in Chief, Xconomy
1:40 – 1:50Opening Remarks
Douglas Williams, EVP, Research and Development, Biogen Idec
1:50 – 2:15
Profile 1: RNAi Therapeutics, Alnylam, and The Carrot Seed
John Maraganore
, CEO, Alnylam Pharmaceuticals
2:15 – 2:45Panel: New Models for Collaboration
Richard Brudnick
, VP, Business Development, Biogen Idec
Robert Urban, Head, J&J Innovation Center, Boston
Jason Rhodes, President and CFO, Epizyme
Rob Armstrong, former VP, Global External Research and Development, Eli Lilly (moderator)
2:45 – 3:15
Chat: Thoughts on the Past, Present, and Future of Biotech
Michael Bonney
, CEO, Cubist Pharmaceuticals
Bob Buderi, Editor in Chief, Xconomy (moderator)
3:15 – 3:45Networking Break
3:45 – 4:10Profile 2: Gene Surgery With CRISPR/Cas9: The Editas Medicine Story
Kevin Bitterman, Interim CEO, Editas Medicine; Partner, Polaris Partners
Feng Zhang, Professor of Biomedical Engineering, MIT
4:10 – 4:35Profile 3: Gene Regulation and Contrarian Drug Development: The Syros Pharmaceuticals Story
Nancy Simonian, CEO, Syros Pharmaceuticals
4:35 – 5:05Panel: New Alternatives for Financing
Roger Stein, Chief Analytics Officer, State Street Global Exchange
Katrine Bosley, Entrepreneur-in-residence, The Broad Institute (moderator)
5:05 – 5:30Profile 4: A Bottoms-Up View of the Microbiome: The Seres Health Story
David Berry, CEO, Seres Health; Partner, Flagship Ventures
5:30 – 6:30Networking Reception
REGISTER NOW: xconomyforum68.eventbrite.com